lunes, 13 de febrero de 2023

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

No hay comentarios:

Publicar un comentario